(2021). Evaluation and validation of a point-of-care type biosensor for the measurement of S100B in plasma as a potential predictor of neurological impairment in traumatic brain injury.
Chicago Style (17th ed.) CitationEvaluation and Validation of a Point-of-care Type Biosensor for the Measurement of S100B in Plasma as a Potential Predictor of Neurological Impairment in Traumatic Brain Injury. 2021.
MLA (8th ed.) CitationEvaluation and Validation of a Point-of-care Type Biosensor for the Measurement of S100B in Plasma as a Potential Predictor of Neurological Impairment in Traumatic Brain Injury. 2021.
Warning: These citations may not always be 100% accurate.